Sodium chloride
- Generic Name
- Sodium chloride
- Brand Names
- Amphenol-40, As 3, Bi-peglyte, Bicart, Bss, Bss Ophthalmic Solution, Cardioplegic, Citrasate, Clinimix E 2.75/5, Colyte, Corvatrol, Dextrose and Electrolyte No. 75, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Eye Stream, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hemosate Ultra, Hespan, Hizentra, Hyperlyte, Intersol, Isolyte S, Isolyte S pH 7.4, Isoplate, Lactate 1-2-3, Lactated Ringers, Menopur, Moviprep, Muro 128, Naturalyte, Normosol-M, Normosol-R, Nulytely, Nxstage Pureflow, P-Care M, P-Care MG, P-care, P-care X, Peglyte, Phoxillum, Physiolyte, Physioneal 40, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Plenvu, Prismasol, Procalamine 3, Ringers, Sag-M, Sclerodex, Suflave, Tis-U-sol
- Drug Type
- Small Molecule
- Chemical Formula
- ClNa
- CAS Number
- 7647-14-5
- Unique Ingredient Identifier
- 451W47IQ8X
- Background
Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential...
- Indication
This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
- Associated Conditions
- Allergic Rhinitis (AR), Corneal Edema, Dehydration, Dehydration Hypertonic, Fluid Loss, Hemodilution, Hypokalemia, Hyponatremia, Hypotonic Dehydration, Hypovolaemia, Increase in Intracranial Pressure (ICP), Increased Intra Ocular Pressure (IOP), Inflammation of the Nasal Mucosa, Isotonic Dehydration, Metabolic Acidosis, Nasal Congestion, Nasal irritation, Oliguria caused by Acute Renal Failure (ARF), Potassium deficiency, Sinusitis, Skin Irritation, Sodium Depletion, Dryness of the nose, Hypochloremic state, Mild Metabolic acidosis, Mild, moderate Metabolic Acidosis
- Associated Therapies
- Electrolyte replacement, Fluid replacement therapy, Heart-Lung-Machine, Oral rehydration therapy, Parenteral Nutrition, Parenteral rehydration therapy, Peritoneal dialysis therapy, Plasma Volume Replacement, Regional Citrate Anticoagulation (RCA), Renal Replacement Therapies, Urine alkalinization therapy, Wound irrigation therapy, Ear wax removal, Fluid and electrolyte maintenance therapy, Increased renal excretion of toxic substances, Maintenance source of fluid and electrolytes, Parenteral drug administration, Reducing brain mass
IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients
- Conditions
- Interventions
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2019-06-03
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 137
- Registration Number
- NCT00567489
- Locations
- 🇭🇰
Prince of Wales Hospital Chinese University of Hong Kong, Sha Tin, N.t., Hong Kong
🇰🇷Kyungpook National University Hospital, Chung-Gu, Deagu, Korea, Republic of
🇰🇷Yeungnam University Medical Center, Nam-gu, Deagu, Korea, Republic of
IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients
- Conditions
- Interventions
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2019-06-03
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 43
- Registration Number
- NCT00567398
- Locations
- 🇦🇺
Westmead Hospital, Sydney, New South Wales, Australia
🇦🇺Gold Coast Hospital, South Port, Australia
🇨🇦University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
Systemic Avastin Therapy in Age-Related Macular Degeneration
- First Posted Date
- 2007-09-18
- Last Posted Date
- 2009-04-22
- Target Recruit Count
- 30
- Registration Number
- NCT00531024
- Locations
- 🇦🇹
Dept. of Ophthalmology, Rudolf Foundation Clinic, Vienna, Austria
Preventing Acute Renal Failure After Cardiac Surgery in High Risk Patients Using Sodium Bicarbonate Therapy
- First Posted Date
- 2007-08-30
- Last Posted Date
- 2012-10-24
- Lead Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Target Recruit Count
- 200
- Registration Number
- NCT00522756
- Locations
- 🇨🇦
McGill University Health Centre - Royal Victoria Hospital, Montreal, Quebec, Canada
Cross-Over Evaluation of Two Lubricating Eye Drops
- Conditions
- First Posted Date
- 2007-06-28
- Last Posted Date
- 2008-01-15
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00493662
- Locations
- 🇺🇸
Hazleton Eye Specialists, Hazleton, Pennsylvania, United States
A Study Of BOTOX For The Treatment Of Glabellar Lines
- Conditions
- Interventions
- First Posted Date
- 2006-12-07
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 256
- Registration Number
- NCT00408785
- Locations
- 🇨🇳
GSK Investigational Site, Shanghai, China
Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine
- Conditions
- First Posted Date
- 2006-07-18
- Last Posted Date
- 2010-02-25
- Lead Sponsor
- Shaare Zedek Medical Center
- Target Recruit Count
- 250
- Registration Number
- NCT00353340
- Locations
- 🇮🇱
Shaare Zmc, Jerusalem, Israel
Intranasal Civamide for Episodic Cluster Headache
- Conditions
- Interventions
- First Posted Date
- 2003-09-16
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- Winston Laboratories
- Target Recruit Count
- 2
- Registration Number
- NCT00069082
- Locations
- 🇺🇸
California Medical Clinic for Headache, Santa Monica, California, United States
🇺🇸Diamond Headache Clinic, Chicago, Illinois, United States
🇺🇸Colorado Neurology and Headache Clinic, Denver, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.